cyclopentane has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barden, A; Croft, KD; Durand, T; Galano, JM; Henry, P; Mas, E; Mori, TA; Roberts, LJ | 1 |
1 other study(ies) available for cyclopentane and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
The effects of oxidation products of arachidonic acid and n3 fatty acids on vascular and platelet function.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Aged; alpha-Linolenic Acid; Animals; Aorta; Arachidonic Acid; Blood Platelets; Cyclopentanes; Docosahexaenoic Acids; Eicosapentaenoic Acid; F2-Isoprostanes; Fatty Acids, Unsaturated; Humans; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Platelet Aggregation; Rats; Rats, Wistar; Young Adult | 2011 |